CDKN2A and pancreatic ductal adenocarcinoma: Molecular profiling reveals that UCOGC consistently harbors canonical mutations in KRAS, CDKN2A, TP53, and SMAD4, aligning its classification within pancreatic ductal adenocarcinoma.